Sameera Ezzat

2.8k total citations
64 papers, 1.3k citations indexed

About

Sameera Ezzat is a scholar working on Epidemiology, Hepatology and Oncology. According to data from OpenAlex, Sameera Ezzat has authored 64 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Epidemiology, 22 papers in Hepatology and 12 papers in Oncology. Recurrent topics in Sameera Ezzat's work include Liver Disease Diagnosis and Treatment (18 papers), Hepatitis C virus research (15 papers) and Hepatitis B Virus Studies (13 papers). Sameera Ezzat is often cited by papers focused on Liver Disease Diagnosis and Treatment (18 papers), Hepatitis C virus research (15 papers) and Hepatitis B Virus Studies (13 papers). Sameera Ezzat collaborates with scholars based in Egypt, United States and Saudi Arabia. Sameera Ezzat's co-authors include Christopher A. Loffredo, Mohamed Abdel‐Hamid, Wafaa M. Rashed, Mohamed A. Kandeil, Mohamed O. Mahmoud, Iman Gouda, Tamer Hifnawy, Mai M. El-Daly, Lenka Goldman and Sherif A. El‐Kafrawy and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Sameera Ezzat

63 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sameera Ezzat Egypt 19 363 347 290 164 157 64 1.3k
Bin Xu China 24 385 1.1× 449 1.3× 169 0.6× 161 1.0× 402 2.6× 96 1.6k
Shuguang Chen China 27 587 1.6× 344 1.0× 311 1.1× 348 2.1× 259 1.6× 83 2.3k
Ke Zhang China 24 734 2.0× 521 1.5× 222 0.8× 79 0.5× 167 1.1× 140 1.9k
Xiaoli Jia China 19 185 0.5× 272 0.8× 196 0.7× 81 0.5× 124 0.8× 65 865
In Hee Kim South Korea 24 595 1.6× 615 1.8× 459 1.6× 277 1.7× 194 1.2× 95 1.8k
Chang‐Fang Chiu Taiwan 19 289 0.8× 202 0.6× 209 0.7× 147 0.9× 359 2.3× 63 1.1k
Larissa Wenning United States 27 560 1.5× 448 1.3× 314 1.1× 169 1.0× 279 1.8× 71 2.9k
Xu Lin China 25 798 2.2× 552 1.6× 286 1.0× 295 1.8× 165 1.1× 81 1.6k
Fei Yu China 22 489 1.3× 538 1.6× 486 1.7× 59 0.4× 189 1.2× 88 2.0k
Tomoko Fujita Japan 18 376 1.0× 196 0.6× 94 0.3× 107 0.7× 99 0.6× 58 1.3k

Countries citing papers authored by Sameera Ezzat

Since Specialization
Citations

This map shows the geographic impact of Sameera Ezzat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sameera Ezzat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sameera Ezzat more than expected).

Fields of papers citing papers by Sameera Ezzat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sameera Ezzat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sameera Ezzat. The network helps show where Sameera Ezzat may publish in the future.

Co-authorship network of co-authors of Sameera Ezzat

This figure shows the co-authorship network connecting the top 25 collaborators of Sameera Ezzat. A scholar is included among the top collaborators of Sameera Ezzat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sameera Ezzat. Sameera Ezzat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ezzat, Sameera, et al.. (2023). KIR Genotypes Impact Progression to Hepatocellular Carcinoma in Patients with Chronic Hepatitis C Infection. SHILAP Revista de lepidopterología. 3(3). 354–368. 1 indexed citations
2.
Ezzat, Sameera, Ivane Gamkrelidze, Asmaa Gomaa, et al.. (2023). Impacts of the Egyptian national screening and treatment programme for viral hepatitis C: A cost‐effectiveness model. Liver International. 43(7). 1417–1426. 6 indexed citations
3.
Farraj, Suha A., et al.. (2022). The pill of recovery; Molnupiravir for treatment of COVID-19 patients; a systematic review. Saudi Pharmaceutical Journal. 30(5). 508–518. 15 indexed citations
4.
Ezzat, Sameera, et al.. (2022). Biobanking in LMIC settings for infectious diseases: Challenges and enablers. Biosafety and Health. 4(5). 290–292. 7 indexed citations
5.
El‐Kassas, Mohamed, Mohamed Alboraie, Naglaa Youssef, et al.. (2020). Retreatment of chronic hepatitis C patients who failed previous therapy with directly acting antivirals: A multicenter study. International Journal of Infectious Diseases. 96. 367–370. 5 indexed citations
6.
Ezzat, Sameera, et al.. (2020). HBVsvp-Pulsed Dendritic Cell Immunotherapy Induces Th1 Polarization and Hepatitis B Virus-Specific Cytotoxic T Lymphocytes Production. SHILAP Revista de lepidopterología. 1 indexed citations
7.
Rashed, Wafaa M., et al.. (2020). MET canonical transcript expression is a predictive biomarker for chemo-sensitivity to MET-inhibitors in hepatocellular carcinoma cell lines. Journal of Cancer Research and Clinical Oncology. 147(1). 167–175. 4 indexed citations
8.
Henderson, Marianne K., Zisis Kozlakidis, Jajah Fachiroh, et al.. (2020). The Responses of Biobanks to COVID-19. Biopreservation and Biobanking. 18(6). 483–491. 15 indexed citations
9.
Dauki, Anees M., James S. Blachly, Esko A. Kautto, et al.. (2019). Transcriptionally Active Androgen Receptor Splice Variants Promote Hepatocellular Carcinoma Progression. Cancer Research. 80(3). 561–575. 29 indexed citations
10.
El‐Kassas, Mohamed, Dalia Omran, Kadry Elsaeed, et al.. (2018). Spur-of-the-Moment Modification in National Treatment Policies Leads to a Surprising HCV Viral Suppression in All Treated Patients: Real-Life Egyptian Experience. Journal of Interferon & Cytokine Research. 38(2). 81–85. 5 indexed citations
11.
Ezzat, Sameera, Wafaa M. Rashed, M. Tevfik Dorak, et al.. (2016). Environmental, maternal, and reproductive risk factors for childhood acute lymphoblastic leukemia in Egypt: a case-control study. BMC Cancer. 16(1). 662–662. 13 indexed citations
12.
Taha, Hala, et al.. (2015). Clinical presentation of intraocular retinoblastoma; 5-year hospital-based registry in Egypt. Journal of the Egyptian National Cancer Institute. 27(4). 195–203. 14 indexed citations
13.
Alfaar, Ahmad Samir, et al.. (2014). Orbital tumors in USA: Difference in survival patterns. Cancer Epidemiology. 38(5). 515–522. 12 indexed citations
14.
Eltabbakh, Mohamed, et al.. (2014). Utility and cost-effectiveness of screening for hepatocellular carcinoma in a resource-limited setting. Medical Oncology. 32(1). 432–432. 19 indexed citations
15.
Ezzat, Sameera, et al.. (2011). Did salvage ICE chemotherapy improve the outcome in primary resistant/relapsing stage III/IV neuroblastoma?. Journal of the Egyptian National Cancer Institute. 23(1). 47–53. 4 indexed citations
16.
Goldman, Radoslav, Habtom W. Ressom, Rency S. Varghese, et al.. (2009). Detection of Hepatocellular Carcinoma Using Glycomic Analysis. Clinical Cancer Research. 15(5). 1808–1813. 123 indexed citations
17.
Goldman, Lenka, Sameera Ezzat, Nadia Mokhtar, et al.. (2009). Viral and non-viral risk factors for non-Hodgkin’s lymphoma in Egypt: heterogeneity by histological and immunological subtypes. Cancer Causes & Control. 20(6). 981–987. 28 indexed citations
18.
Sidhom, Iman, et al.. (2008). Clinical significance of immunophenotypic markers in pediatric T-cell acute lymphoblastic leukemia.. PubMed. 20(2). 111–20. 9 indexed citations
19.
El‐Kafrawy, Sherif A., Mohamed Abdel‐Hamid, Mai M. El-Daly, et al.. (2005). p53 Mutations in hepatocellular carcinoma patients in Egypt. International Journal of Hygiene and Environmental Health. 208(4). 263–270. 25 indexed citations
20.
Ezzat, Sameera, Mohamed Abdel‐Hamid, Nadia Mokhtar, et al.. (2005). Associations of pesticides, HCV, HBV, and hepatocellular carcinoma in Egypt. International Journal of Hygiene and Environmental Health. 208(5). 329–339. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bin Xu Breakdown of academic impact, for papers by Shuguang Chen Breakdown of academic impact, for papers by Ke Zhang Breakdown of academic impact, for papers by Xiaoli Jia Breakdown of academic impact, for papers by In Hee Kim Breakdown of academic impact, for papers by Chang‐Fang Chiu Breakdown of academic impact, for papers by Larissa Wenning Breakdown of academic impact, for papers by Xu Lin Breakdown of academic impact, for papers by Fei Yu Breakdown of academic impact, for papers by Tomoko Fujita
Rankless by CCL
2026